Currently 9.7 million people in Europe already live with Alzheimer’s Disease and dementia[1] – and this number is projected to rise to 14 million by 2030.[2]...
Hello and welcome, health colleagues, to the second update of the week from the European Alliance for Personalised Medicine (EAPM). There is plenty of news today...
This week, the European Medicines Agency (EMA) launched its PRIME scheme. This stands for PRIority MEdicines and is intended to “strengthen support to medicines that target...
